PURPOSE: To investigate HIV transmission potential from a cluster of HIV infections among men who have sex with men to persons who inject drugs in 15 West Virginia counties. These counties were previously identified as highly vulnerable to rapid HIV dissemination through injection drug use (IDU) associated with high levels of opioid misuse. METHODS: We interviewed persons with 2017 HIV diagnoses about past-year risk behaviors and elicited sexual, IDU, and social contacts. We tested contacts for HIV and assessed risk behaviors. To determine HIV transmission potential from persons with 2017 diagnoses to persons who inject drugs, we assessed viral suppression status, HIV status of contacts, and IDU risk behaviors of persons living with HIV and contacts. RESULTS: We interviewed 78 persons: 39 with 2017 diagnoses and 39 contacts. Overall, 13/78 (17%) injected drugs in the past year. Of 19 persons with 2017 diagnoses and detectable virus, 9 (47%) had more than or equal to 1 sexual or IDU contacts of negative or unknown HIV status. During the past year, 2/9 had injected drugs and shared equipment, and 1/9 had more than or equal to 1 partner who did so. CONCLUSIONS: We identified IDU risk behavior among persons with 2017 diagnoses and their contacts. West Virginia HIV prevention programs should continue to give high priority to IDU harm reduction.
PURPOSE: To investigate HIV transmission potential from a cluster of HIV infections among men who have sex with men to persons who inject drugs in 15 West Virginia counties. These counties were previously identified as highly vulnerable to rapid HIV dissemination through injection drug use (IDU) associated with high levels of opioid misuse. METHODS: We interviewed persons with 2017 HIV diagnoses about past-year risk behaviors and elicited sexual, IDU, and social contacts. We tested contacts for HIV and assessed risk behaviors. To determine HIV transmission potential from persons with 2017 diagnoses to persons who inject drugs, we assessed viral suppression status, HIV status of contacts, and IDU risk behaviors of persons living with HIV and contacts. RESULTS: We interviewed 78 persons: 39 with 2017 diagnoses and 39 contacts. Overall, 13/78 (17%) injected drugs in the past year. Of 19 persons with 2017 diagnoses and detectable virus, 9 (47%) had more than or equal to 1 sexual or IDU contacts of negative or unknown HIV status. During the past year, 2/9 had injected drugs and shared equipment, and 1/9 had more than or equal to 1 partner who did so. CONCLUSIONS: We identified IDU risk behavior among persons with 2017 diagnoses and their contacts. West Virginia HIV prevention programs should continue to give high priority to IDU harm reduction.
Authors: Jennifer L Glick; Suzanne M Grieb; Samantha J Harris; Brian W Weir; Katherine C Smith; Tyler Puryear; Rebecca Hamilton White; Sean T Allen Journal: Harm Reduct J Date: 2022-05-19
Authors: Heather Bradley; Elizabeth M Rosenthal; Meredith A Barranco; Tomoko Udo; Patrick S Sullivan; Eli S Rosenberg Journal: J Infect Dis Date: 2020-09-02 Impact factor: 5.226
Authors: Nathan W Furukawa; Mathew Weimer; Kara S Willenburg; Michael E Kilkenny; Amy D Atkins; R Paul McClung; Zachary Hansen; Kathleen Napier; Senad Handanagic; Neal A Carnes; Jeffrey Kemp Rinderle; Robyn Neblett-Fanfair; Alexandra M Oster; Dawn K Smith Journal: Public Health Rep Date: 2021-03-01 Impact factor: 2.792
Authors: Chan Jin; Ndidi Nwangwu-Ike; Zanetta Gant; Shacara Johnson Lyons; Anna Satcher Johnson Journal: Public Health Rep Date: 2021-04-21 Impact factor: 3.117
Authors: Luiz Fernando Almeida Machado; Ricardo Roberto de Souza Fonseca; Maria Alice Freitas Queiroz; Aldemir Branco Oliveira-Filho; Izaura Maria Vieira Cayres-Vallinoto; Antonio Carlos Rosário Vallinoto; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak Journal: Viruses Date: 2021-05-07 Impact factor: 5.048
Authors: Ann M Dennis; Simon D W Frost; Kimberly Enders; Andrew E Cressman; Erik Volz; Nicole Adams; William C Miller; Myron S Cohen; Victoria Mobley; Erika Samoff; Joseph J Eron Journal: EClinicalMedicine Date: 2021-06-17
Authors: Pamela W Klein; Tanya Geiger; Nicole S Chavis; Stacy M Cohen; Alexa B Ofori; Kathryn T Umali; Heather Hauck Journal: PLoS One Date: 2020-03-23 Impact factor: 3.240